Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
4
result was found. Results that relate to
Anti-tumor
Review and risk information management of neuropathy induced by emerging anti-tumor drugs
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(1):9-18.
2042 times
629 times
LYU Feng
SONG Wei
XIN Mengru
XIE Di
ZHANG Wenqing
HE Wen
HU Hankun
Emerging anti-tumor drugs
Drug-induced neuropathy
Drug risk information management
Details
Research progress on processing technology, chemical constituents and pharmacological activities of Polygoni multiflori radix praeparata
Published on
Frontiers in Pharmaceutical Sciences
2024,28(3):523-535.
2405 times
369 times
YAO Rui
GUO Hong
ZHANG Xiaoshu
WANG Ying
GUO Xiaohan
CHEN Jia
LI Jinhao
XU Ling
YANG Jianbo
JING Wenguang
CHENG Xianlong
WEI Feng
Polygoni multiflori radix praeparata
Processing technology
Chemical constituents
Stilbene glycosides
Anthraquinones
Flavonoids
Alkaloids
Phenolic acids
Pharmacological activity
Antioxidant
Antianemic
Anti-tumor
Hypoglycemic
Anti- inflammatory
Details
Research progress on anti-tumor effect of monoterpene indole alkaloids in Uncariae Ramulus Cum Uncis
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(1):86-93.
1848 times
209 times
YU Dahai
DONG Xue
ZHAO Lizhu
Uncariae Ramulus Cum Uncis
Monoterpene indole alkaloids
Anti-tumor
Rhynchophylline
Isorhynchophylline
Hirsutine
Hirsuteine
Isocorynoxeine
Details
Analysis on application of new anti-tumor drugs for respiratory system in 121 hospitals in China from 2019 to 2022
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(1):27-34.
961 times
134 times
XING Yue
LIU Tong
ZHONG Lu
JIN Yao
TENG Xue
New anti-tumor drugs for respiratory system
Targeted drugs
Immunotherapy drugs
DDDs
DDC
Ranking ratio
Drug utilization
Details